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Genetic Susceptibility for Childhood BMI has no Impact 
on Weight Loss Following Lifestyle Intervention  
in Danish Children
Mette Hollensted1,2*, Mette Fogh3,4*, Theresia M. Schnurr1,2*, Julie T. Kloppenborg3, Christian T. Have1,  
Tenna Ruest Haarmark Nielsen3, Johanne Rask3, Morten Asp Vonsild Lund3,5, Christine Frithioff-Bøjsøe1,3,  
Mia Østergaard Johansen3, Emil Vincent Rosenbaum Appel1, Yuvaraj Mahendran1, Niels Grarup1,  
Haja N. Kadarmideen6, Oluf Pedersen1, Jens-Christian Holm1,3, and Torben Hansen1
Objective: This study aimed to investigate the effect of a genetic risk score (GRS) comprising 15 single-
nucleotide polymorphisms, previously shown to associate with childhood BMI, on the baseline cardiometa-
bolic traits and the response to a lifestyle intervention in Danish children and adolescents.
Methods: Children and adolescents with overweight or obesity (n = 920) and a population-based control sample 
(n = 698) were recruited. Anthropometric and biochemical measures were obtained at baseline and in a subgroup 
of children and adolescents with overweight or obesity again after 6 to 24 months of lifestyle intervention (n = 754). 
The effects of the GRS were examined by multiple linear regressions using additive genetic models.
Results: At baseline, the GRS associated with BMI standard deviation score (SDS) both in children and ado-
lescents with overweight or obesity (β = 0.033 [SE = 0.01]; P = 0.001) and in the population-based sample 
(β = 0.065 [SE = 0.02]; P = 0.001). No associations were observed for cardiometabolic traits. The GRS did not 
influence changes in BMI SDS or cardiometabolic traits following lifestyle intervention.
Conclusions: A GRS for childhood BMI was associated with BMI SDS but not with other cardiometabolic 
traits in Danish children and adolescents. The GRS did not influence treatment response following lifestyle 
intervention.
Obesity (2018) 26, 1915-1922. doi:10.1002/oby.22308
Introduction
Obesity is a complex condition with multiple contributing factors, 
such as environmental and lifestyle factors, genetic susceptibility, and 
alterations in the gut microbiome (1-4), and children with obesity have 
a greater risk of developing metabolic and cardiovascular disorders 
(1,5). Obesity is highly heritable, and family, twin, and adoption stud-
ies have reported heritability estimates of 40% to 70% for BMI (6-9).
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The largest available genome-wide association meta-analysis compris-
ing up to 47,541 children aged 2 to 10 years identified 15 genome-wide 
significant loci associated with childhood BMI (10). In a subset of 1,955 
children, the authors showed that a genetic risk score (GRS) comprising 
these 15 loci explained 2.0% of the variance in childhood BMI (10).
It is not known whether children with a high genetic susceptibility for 
childhood obesity, as assessed by a GRS, will respond differently to life-
style intervention. Treatment and prevention strategies may be improved 
by a deeper understanding of the underlying molecular mechanisms of 
obesity and by early identification of individuals at higher risk for devel-
oping obesity and related comorbidities. The heritable genetic influence 
on BMI increases during childhood, peaks around 20 years of age, and 
then weakens during adulthood (8,10-14), indicating that genetic vari-
ation has its strongest effect on BMI during early life. Nevertheless, 
children and adolescents are highly influenced by behavioral, social, 
parental, and environmental factors and may therefore be susceptible 
to lifestyle interventions (11). In a previous pediatric lifestyle interven-
tion study (n = 168), a GRS comprising nine BMI susceptibility loci 
was inversely associated with changes in BMI standard deviation score 
(SDS) and fat mass. However, the sample size was relatively small, and 
the GRS not only comprised childhood specific loci but also included 
loci found to be associated with BMI in adult populations (15).
The objectives for this present study were to investigate whether a GRS 
comprising 15 loci for childhood BMI associates with (1) BMI SDS 
and the overall cardiometabolic risk profile in Danish children and ado-
lescents and (2) the response to lifestyle intervention in children and 
adolescents with overweight or obesity.
Methods
Study population
Data for this study were from The Danish Childhood Obesity Biobank 
(ClinicalTrials.gov identifier NCT00928473), comprising data from 
children and adolescents with normal weight, overweight, or obesity. 
Data material was collected between March 2007 and March 2015. A 
total of 1,069 children and adolescents (aged 6-18 years) with over-
weight or obesity were recruited through The Children’s Obesity Clinic, 
Department of Pediatrics, Copenhagen University Hospital Holbæk in 
Denmark. Overweight was defined as a BMI above the 90th percen-
tile (BMI SDS > 1.28) according to age and sex in a Danish reference 
population (16). Between September 2010 and March 2013, a popula-
tion-based control sample of 719 Danish children and adolescents aged 
6 to 18 years was recruited from schools across 11 municipalities in 
Denmark.
This study was conducted in accordance with the Helsinki Declaration 
of 1983. An informed written and oral consent was obtained from all 
participants or from their parents if the participant was younger than 
18 years of age. This study was approved by the Ethics Committee of 
Region Zealand, Denmark (ID number SJ-104), and by the Danish Data 
Protection Agency.
Clinical examination
Anthropometric measurements. Height was measured using a stadi-
ometer to the nearest 0.1 cm, and weight was measured to the nearest 
0.1 kg on a Tanita BC418 scale (Tanita Corp., Tokyo, Japan) in the 
population-based control sample and on a Tanita digital medical scale, 
WB-110 MA in the children and adolescents with overweight or obe-
sity. All measurements were conducted with the child or adolescent 
wearing light indoor clothes and without shoes. BMI was calculated as 
the weight in kilograms divided by the height in meters squared. BMI 
SDS was calculated using the LMS (Lambda for the skew, Mu for the 
median, and Sigma for the generalized coefficient of variation) meth-
ods (17) and expresses the standard deviation from the mean BMI in a 
representative Danish population (16).
Blood pressure (BP). A total of three BP measurements were made, 
and the mean of the last two measurements was reported. Hereafter, 
BP SDS was calculated according to an American reference population 
(18). BP was measured with the oscillometric device Omron 705IT 
(Omron Healthcare Europe, Hoofddorp, The Netherlands) on the 
right upper arm using an appropriate cuff size, a method that has been 
validated for use in children and adolescents (19).
Blood sampling. Venous blood samples were drawn from an 
antecubital vein after a 12-hour overnight fast. If required, a local 
anesthetic cream (lidocaine/prilocain mixture; Emla, AstraZeneca, 
Stockholm, Sweden) was applied 1 hour prior to venipuncture. The 
blood was analyzed immediately after venipuncture. A Cobas 6000 
(Roche Diagnostics, Mannheim, Germany) was used to analyze serum 
concentrations of fasting plasma glucose, hemoglobin A1c (HbA1c), 
low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein 
cholesterol (HDL-C), total cholesterol, and triglycerides.
When the interval between the date of the clinical examination and the 
date of the blood sample exceeded 30 days, biochemical measurements 
for the respective participant were excluded from our analyses.
Lifestyle intervention in children and adolescents 
with overweight or obesity
The lifestyle intervention consisted of an evidence-based treatment 
protocol, which was developed at the Department of Pediatrics at the 
Copenhagen University Hospital Holbæk in 2007 (20,21). The treat-
ment protocol is based on the recommendations from the Expert 
Committee from 2007 (22). This protocol is family-centered and 
multidisciplinary and it comprises a range of behavioral lifestyle rec-
ommendations. The treatment is delivered by a team of pediatricians, 
dietitians, pediatric nurses, psychologists, and social workers. The rec-
ommended lifestyle changes are applicable for the entire family, and 
all family members are encouraged to attend the consultations. At the 
initial 1-hour consultation, a pediatrician obtains a detailed medical 
history and conducts a questionnaire-based interview aimed at identi-
fying all the lifestyle changes necessary to reduce the patient’s degree 
of overweight or obesity. These lifestyle changes are incorporated into 
an individualized treatment plan containing 15 to 20 items of advice 
regarding the implementation of the lifestyle changes into the daily 
lives of the families. Examples of lifestyle changes include dietary 
habits, means of transportation, physical activity, sedentary behaviors, 
sleep time, snacking, social activities, and sweets intake. At this con-
sultation and at all subsequent consultations, the treatment plan is eval-
uated and adjusted to accommodate the specific challenges and needs 
of the families. Details of the treatment protocol have been reported in 
Holm et al. (20).
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Genotyping
Genotyping was performed on 1,788 individuals using the Illumina 
Infinium HumanCoreExome BeadChip (Illumina, San Diego, 
California). Genotypes were called using the Genotyping module 
(version 1.9.4) of GenomeStudio Software (version 2011.1; Illumina). 
We excluded individuals identified as duplicates, ethnic outliers, or 
with extreme inbreeding coefficients, mislabeled gender, or a call-
rate < 95%, leaving 1,618 individuals (noverweight/obesity = 920, npopula-
tion-based sample = 698) who passed all quality control criteria. Additional 
genotypes were imputed into the 1000 Genomes phase 1 panel using 
IMPUTE2. The imputation quality was high (INFO score > 0.95) for 
all imputed variants included in the current study and GRS construc-
tion, except for one (rs13387838, INFO score = 0.77). All variants were 
in Hardy-Weinberg equilibrium (P > 0.05).
GRS construction
Genotypes were coded according to the number of BMI-increasing al-
leles based on 15 independent loci previously shown to be associated 
with childhood BMI at genome-wide significance (P < 5 × 10-8) (10). 
We constructed a weighted GRS (wGRS) by summing the number of 
BMI-increasing alleles weighted by the effect size of the variant es-
timated in the genome-wide association discovery study (10) and an 
unweighted GRS (uGRS) by summing the number of BMI-increasing 
alleles. Seven of the fifteen BMI single-nucleotide polymorphisms 
(SNPs) identified in the genome-wide association discovery study 
(rs7550711, rs543874, rs13130484, rs987237, rs7132908, rs12429545, 
rs1421085) were directly genotyped, while the remaining genotypes 
(rs3829849, rs4854349, rs6567160, rs8092503, rs11676272, rs12041852, 
rs13253111, rs13387838) were retrieved from imputed data, and the de-
rived dosage information for the SNPs was included into the GRS cal-
culation (Supporting Information Table S1).
Statistical analyses
We included all children and adolescents with eligible data at baseline 
in our analysis. In analyses focusing on the lifestyle intervention out-
come, only individuals having completed 6 to 24 months of lifestyle 
intervention were included. Furthermore, we performed all statistical 
analyses with and without inclusion of individuals with diseases, con-
ditions, or medication intake that may have an effect on weight and/
or appetite regulation (n = 72 individuals). Prior to statistical analy-
ses, non-normally distributed traits at baseline (fasting blood glucose, 
LDL-C, and triglycerides) and following intervention (fasting blood 
glucose, HDL-C, LDL-C, and triglycerides) were logarithmically 
transformed to comply with the assumption of normal distribution.
All statistical analyses were performed using the statistical software 
program R (version 3.3.0; The R Foundation for Statistical Computing, 
Boston, Massachusetts). At baseline, differences in anthropometric and 
biochemical measures between study samples were examined using 
unpaired t tests, while the difference in sex ratios between study samples 
was evaluated using Pearson χ2 test. The effects of the wGRS and uGRS 
on cardiometabolic traits were estimated using multiple linear regres-
sions while adjusting for the first three genome-wide principal compo-
nents, age, age2, and sex, as appropriate. When analyzing the lifestyle 
intervention response outcome, linear multiple regressions were used to 
calculate the association between the wGRS and uGRS with end-point 
values while adjusting for the first three genome-wide principal com-
ponents, treatment duration, and baseline value of the examined trait, as 
well as age, age2, and sex, as appropriate. Furthermore, end-point values 
of biochemical measures were analyzed with and without adjustment 
for baseline BMI SDS. While non-normally distributed traits were loga-
rithmically transformed to achieve a normal distribution, and respective 
P values are given from analyses of logarithmically transformed traits, 
all effect sizes (β) and standard errors (SE) are given from analyses of 
nonstandardized traits.
When estimating statistical power of the present analyses, we took into 
account that we are using imputed markers for many of the SNPs in 
the GRS. Our power calculation was based on a simulation in which, 
for a randomly sampled population of 10,000 individuals, the per-allele 
effects on a random normal phenotype (mean = 0 [SD 1]) correspond to 
the weights specified in the wGRS, but the imputed dosages correlate 
to the degree implied by the imputation quality INFO score from our 
real imputed data. Statistical power is calculated by repeatedly subsam-
pling to a specific sample size and testing whether a P < 0.05 phenotype 
correlation exists for a GRS constructed from the dosages (Supporting 
Information Figure S1).
For our primary hypothesis, BMI SDS, P < 0.05 was considered statis-
tically significant. For secondary hypotheses, we performed 16 tests (8 
cardiometabolic traits tested in the two different groups of children), 
and a P of 0.05/16 = 0.0031 was considered statistically significant.
Results
Baseline characteristics
During the study period, 1,618 children and adolescents (935 girls) 
were included. Children and adolescents with overweight or obesity 
were younger (median age: 11.63 years; interquartile range: 9.59-
13.87) compared with the population-based control sample (median 
age: 12.50 years; interquartile range: 10.09-15.10; P < 0.001) (Table 1).
Association between GRS and anthropometry at 
baseline
Our results did not differ on inclusion of individuals (n = 72) with 
diseases, conditions, or medication intake with a potential effect on 
weight and/or appetite regulation, so results obtained in the full data 
set are provided. The wGRS was associated with a 0.033-higher BMI 
SDS (SE: 0.01; P = 0.001) per risk allele in children and adolescents 
with overweight or obesity and with a 0.065-higher BMI SDS in the 
population-based control study sample (SE: 0.02; P = 0.001) (Table 2). 
Similarly, a positive association in both study samples was observed 
when analyzing the uGRS (Supporting Information Table S2). No as-
sociations with systolic or diastolic BP were observed for the wGRS or 
the uGRS (Table 2 and Supporting Information Table S2, respectively).
Furthermore, we performed additional sensitivity analyses to investi-
gate whether there was an age effect on the association between the 
wGRS and BMI SDS in children with overweight or obesity. For this, 
we stratified the study population into three age groups (6-10, >10-14, 
and >14-18 years) and observed a significant positive association of the 
wGRS, with BMI SDS only in the two oldest age groups (>10-14 and 
>14-18 years) (Figure 1). However, there was no interaction between 
the wGRS and age on BMI SDS in children with overweight or obe-
sity when performing a formal test for interaction (P > 0.05, data not 
shown).
Obesity
1918    Obesity | VOLUME 26 | NUMBER 12 | DECEMBER 2018 www.obesityjournal.org
Childhood Obesity Gene Risk: Intervention Outcome Hollensted et al.
TABLE 2 Association between weighted GRS and metabolic traits
Children and adolescents with overweight or 
obesity Population-based control sample
n β (SE) P n β (SE) P
BMI SDS 920 0.033 (0.01) 0.001 698 0.065 (0.02) 0.001
Systolic BP SDS 855 −0.003 (0.02) 0.89 664 0.04 (0.03) 0.13
Diastolic BP SDS 855 0.01 (0.01) 0.45 664 0.001 (0.01) 0.95
Biochemical measures 
obtained after fasting
Glucose (mmol/L) 702 0.002 (0.01) 0.60a,b 683 −0.01 (0.02) 0.71a,b
HbA1c (mmol/mol) 730 0.01 (0.07) 0.91a 655 −0.05 (0.07) 0.50a
LDL-C (mmol/L) 723 −0.002 (0.01) 0.90a,b 655 −0.01 (0.01) 0.19a,b
HDL-C (mmol/L) 723 0.003 (0.01) 0.51a 655 0.0002 (0.01) 0.98a
Total cholesterol (mmol/L) 723 −0.001 (0.02) 0.93a 655 −0.02 (0.01) 0.23a
Triglycerides (mmol/L) 723 −0.001 (0.01) 0.91a,b 655 −0.004 (0.01) 0.21a,b
Results shown for weighted GRS. Effect sizes and standard errors (SE) calculated using untransformed variables. P values calculated using either untransformed or log trans-
formed variables. Analyses adjusted for first three genome-wide principal components.
aAnalyses adjusted for age, age2, and sex.
bP value calculated using logarithmically transformed variables.
P values in bold indicate P < 0.05.
BP, blood pressure; GRS, genetic risk score; HbA1c, hemoglobin A1c; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; SDS, standard 
deviation score.
TABLE 1 Study population characteristics
Children and adolescents with 
overweight or obesity Population-based control sample
Differences  
between groups
n Median (IQR) n Median (IQR) P
Sex (girls/boys) 514/406 − 421/277 − NS
Age (y) 920 11.63 (9.59-13.87) 698 12.50 (10.09-15.10) *
BMI SDS 920 2.87 (2.47-3.29) 698 0.33 (−0.38-1.01) *
Systolic BP SDS 855 1.54 (0.71-2.55) 664 1.56 (0.77-2.58) NS
Diastolic BP SDS 855 0.54 (0.04-1.12) 664 0.41 (−0.02-0.85) *
Biochemical measures 
obtained after fasting
Glucose (mmol/L) 703 5.10 (4.90-5.40) 685 4.97 (4.75-5.19) *
HbA1c (mmol/mol) 730 34.00 (33.00-37.00) 655 35.00 (33.00-36.00) NS
LDL-C (mmol/L) 723 2.50 (2.10-3.00) 655 2.10 (1.80-2.50) *
HDL-C (mmol/L) 723 1.20 (1.00-1.40) 655 1.50 (1.30-1.70) *
Total cholesterol (mmol/L) 723 4.20 (3.70-4.80) 655 3.900 (3.60-4.40) *
Triglycerides (mmol/L) 723 0.90 (0.70-1.30) 655 0.60 (0.50-0.80) *
*P < 0.001.
BP, blood pressure; HbA1c, hemoglobin A1c; HDL-C, high-density lipoprotein cholesterol; IQR, interquartile range; LDL-C, low-density lipoprotein cholesterol; NS, not significant; 
SDS, standard deviation score.
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Association between GRS and biochemical 
measures obtained after fasting at baseline
No associations were identified between the wGRS and fasting plasma 
glucose, HbA1c, LDL-C, HDL-C, total cholesterol, or triglycerides in 
the children and adolescents with overweight and obesity or in the pop-
ulation-based control sample (all P > 0.20) (Table 2). Similar results 
were found for the uGRS (Supporting Information Table S2).
Association between GRS and trait-specific 
principal components at baseline
Considering that most of the BMI-related cardiometabolic traits are 
correlated, we performed additional analyses by producing trait-spe-
cific principal components instead of studying the genetic associations 
with individual cardiometabolic traits at baseline (Supporting infor-
mation Figure S2). The trait-specific principal component showing 
negative trait correlations with total cholesterol, LDL-C, and HDL-C 
as well as BMI SDS was negatively associated with the wGRS in chil-
dren and adolescents with overweight or obesity (P = 0.034 [unadjusted 
P value]; Supporting Information Figure S2). In contrast, the trait-spe-
cific principal component showing negative trait correlations with 
HbA1c, triglycerides, total cholesterol, and LDL-C and a positive trait 
correlation with BMI SDS was positively associated with the wGRS in 
the population-based control sample (P = 0.018 [unadjusted P value]; 
Supporting Information Figure S2). Both associations were not sta-
tistically significant after applying Bonferroni correction for multiple 
testing and hence presented null findings.
Association between GRS and response to 
lifestyle intervention
The influence of the GRS on lifestyle intervention outcome was in-
vestigated in a subgroup of 754 children and adolescents with over-
weight or obesity. The wGRS did not influence changes in BMI SDS 
(β = −0.007 [SE: 0.01]; P = 0.34) (Table 3). The same result was found 
after stratifying the subgroup into age groups (6-10, >10-14, and >14-18 
years; data not shown).
The wGRS showed a nominal positive association with changes in sys-
tolic BP SDS (β = 0.039 [SE: 0.02]; P = 0.039) (Table 3), yet this asso-
ciation became insignificant upon adjustment for baseline BMI SDS 
(P = 0.06). In addition, the wGRS associated nominally with changes 
in HbA1c concentrations (β = −0.104 mmol/mol [SE: 0.05]; P = 0.027) 
(Table 3). None of these associations remained statistically significant 
upon correction for multiple testing (data not shown). Similar associ-
ations were found for the uGRS (Supporting Information Table S3).
SNP-specific associations with baseline BMI 
SDS and changes in BMI SDS following lifestyle 
intervention
In addition to examining the cumulative effect of the 15 SNPs compos-
ing the GRS, SNP-specific associations with baseline BMI SDS and 
changes in BMI SDS following intervention were also examined. In 
children and adolescents with overweight or obesity, overall, 12 SNPs 
showed the expected direction of effect (i.e., BMI SDS increasing), 
while SEC16B rs543874 and FTO rs1421085 were nominally associ-
ated with baseline BMI SDS (β = 0.07 [SE: 0.03], P = 0.04, and β = 0.06 
[SE: 0.03], P = 0.05, respectively). Only one SNP, LMX1B rs3829849, 
was significantly associated with decreased change in BMI SDS fol-
lowing intervention (i.e., a lower degree of weight loss) (Supporting 
Information Table S1). Similarly, 12 out of the 15 SNPs showed the ex-
pected direction of effect in the population-based control group, while 
only TMEM18 rs4854349 significantly associated with baseline BMI 
SDS (β = 0.19 [SE: 0.08]; P = 0.01) (Supporting Information Table S1).
Discussion
The present study demonstrates that a GRS comprising 15 known 
childhood BMI susceptibility loci was associated (as expected) with 
BMI SDS but not with the overall cardiometabolic risk profile in 
Danish children and adolescents. We further showed that the interven-
tion response of children and adolescents with overweight or obesity 
was independent of their genetic susceptibility to childhood obesity 
across all examined age groups.
While we found that the wGRS displayed the highest effect estimate 
on BMI SDS (0.065 increase in BMI SDS per weighted risk allele) 
in the population-based control sample compared with the sample of 
children and adolescents with overweight or obesity (0.033 increase in 
BMI SDS per weighted risk allele), these effect sizes were not signifi-
cantly different from each other. A similar allelic effect of the GRS on 
BMI SDS at adiposity peak (β = 0.039; 95% CI: 0.006-0.073; P = 0.023) 
was reported in a population-based sample of children (n = 3,975; mean 
age: 6 years; range 5.7-7.8) (23). Our observed allelic effect of the 
wGRS was, however, slightly smaller compared with the 0.073 increase 
in BMI SDS that was reported in the discovery study (n = 1,955; age 
range: 2-10 years) (10).
We observed no association between the wGRS and BMI SDS in chil-
dren and adolescents aged 6 to 10 years when stratifying our popu-
lation into three age groups. This discrepancy may be due to our 
Figure 1 Association of the weighted genetic risk score on baseline BMI 
SDS in children with overweight or obesity (ntotal = 920) when stratified into 
three age groups. BMI SDS, body mass index standard deviation score.
6−10 years (n = 277)
>10−14 years (n = 425)
>14−18 years (n = 218)
−0.025 0 0.025 0.05 0.075
Effect on BMI SDS per risk allele
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smaller sample size in this age group (n = 277) and the reduced statis-
tical power when investigating the age-group-specific associations, as 
demonstrated in Supporting Information Figure S1. Nevertheless, it is 
noteworthy that the present study demonstrated a significant positive 
association between the wGRS and BMI SDS in children and adoles-
cents aged >10 to 18 years, suggesting that in a Danish population, 
the included 15 loci also exerted a significant cumulative effect on 
BMI SDS in children older than 10 years. The two previous studies 
reported larger effect estimates for the BMI GRS in children compared 
with adults (10,23), suggesting that these loci displayed age-dependent 
effects. Age-dependent effects have previously been demonstrated for 
the alpha-ketoglutarate dependent dioxygenase (FTO) (11,13) and the 
melanocortin 4 receptor (MC4R) loci (24), with genetic effects ini-
tially strengthening in the age range of 3 to 7 years (25) and decreas-
ing during adulthood, potentially because of an increasing influence 
of environmental factors and gene-environment interactions throughout 
a life course (8,13). Both the FTO and MC4R loci were included in 
the GRS, and other included loci may also exert age-dependent effects. 
When examining the SNP-specific effects of the 15 included SNPs on 
baseline BMI SDS, nominally significant associations were identified 
for only three SNPs (SEC16B rs543874, FTO rs1421085, and TMEM18 
rs4854349). However, a positive direction of effect was observed for the 
majority, namely 12 out of 15, SNPs in both children and adolescents 
with overweight and obesity as well as the population-based sample. 
Furthermore, only one SNP (LMX1B rs3829849) was associated with 
decreased change in BMI SDS following intervention. Nevertheless, 
given our limited statistical power to detect SNP-specific associations, 
these results should be interpreted cautiously.
In the present study, the GRS showed no significant association with 
BMI-related cardiometabolic traits, suggesting that the 15 included loci 
have no cumulative effect on these traits, at least not an effect that is 
strong enough to be detected in our study. Similarly, previous studies 
examining the combined effect of SNPs in or near the FTO or MC4R 
loci on anthropometric or metabolic measures in children have observed 
no significant associations (26,27). Several other studies have indicated 
that both childhood and adulthood BMI susceptibility loci are also asso-
ciated with eating behavior, particularly appetite regulation (3,23,28), 
food intake, and energy expenditure (29), which is mediated through 
the central nervous system. Eating behavior could complicate the asso-
ciations but was not investigated in the present study. In sensitivity anal-
ysis, we tested the association between GRS and trait-specific principal 
components instead of studying the genetic association with individual 
cardiometabolic traits, but the results presented null findings. While 
it could be interesting to study the drivers behind these trait-specific 
principal component associations in more detail, this would warrant a 
larger sample size. Therefore, the results of these additional trait-spe-
cific principal component analyses can only be speculative and should 
be interpreted with caution.
No effect of GRS on changes in BMI SDS was found across all exam-
ined age groups. While the GRS was initially inversely associated with 
changes in systolic BP and concentrations of HbA1c, these associations 
were insignificant when corrected for multiple testing. Our findings 
indicate that children and adolescents with a high genetic susceptibility 
based on the 15 selected SNPs are likely to respond to the same degree 
and to achieve a similar decrease in degree of obesity following lifestyle 
intervention compared with individuals with a lower genetic suscepti-
bility. Several studies have examined the effects of single adulthood or 
childhood BMI and/or obesity susceptibility SNPs or loci on obesity 
intervention outcome. However, these studies have generally been per-
formed in smaller study populations, and the durations of the applied 
interventions have been limited (26,27,30-35).
Moleres et al. (15) constructed a GRS comprising nine obesity sus-
ceptibility SNPs (in or near MC4R, FTO, PPARG, TMEM18, IL6, and 
ADPOQ) previously identified in adult populations and examined the 
association between this GRS and the response to a lifestyle intervention 
TABLE 3 Effect of weighted GRS on intervention response in children with overweight or obesity
Children and adolescents 
following intervention
Intervention 
response
Per allelic effect 
of GRS
n Median (IQR) Median Δ (IQR) β (SE) P
Duration of intervention (y) 754 1.25 (1.00 to 1.59) NA NA NA
BMI SDS 754 2.63 (2.09 to 3.10) −0.20 (−0.50 to 0.01) −0.01 (0.01) 0.34
Systolic BP SDS 600 1.70 (0.90 to 2.68) 0.24 (−0.39 to 0.99) 0.04 (0.02) 0.039
Diastolic BP SDS 600 0.52 (0.06 to 1.03) 0.04 (−0.46 to 0.57) −0.01 (0.01) 0.60
Biochemical measures obtained 
after fasting
Glucose (mmol/L) 403 5.10 (4.90 to 5.40) 0.10 (−0.35 to 0.40) −0.01 (0.01) 0.89a,b
HbA1c (mmol/mol) 427 34.00 (32.00 to 37.00) 0.00 (−2.00 to 1.00) −0.10 (0.05) 0.027a
LDL-C (mmol/L) 424 2.30 (1.900 to 2.700) −0.10 (−0.40 to 0.20) 0.01 (0.01) 0.58a,b
HDL-C (mmol/L) 426 1.20 (1.10 to 1.50) 0.10 (−0.10 to 0.20) 0.0003 (0.005) 0.95a
Total cholesterol (mmol/L) 425 4.10 (3.70 to 4.50) −0.10 (−0.40 to 0.30) 0.007 (0.01) 0.70a,b
Triglycerides (mmol/L) 425 0.90 (0.60 to 1.20) 0.00 (−0.30 to 0.20) −0.003 (0.01) 0.79a,b
Median outcome for all traits following 6 to 24 months of intervention. Per allelic effects shown for weighted GRS. Effect sizes and standard errors (SE) calculated using untrans-
formed variables. Analyses adjusted for first three genome-wide principal components. All analyses adjusted for baseline value and intervention duration. BP, blood pressure; 
GRS, genetic risk score; HbA1c, hemoglobin A1c; HDL-C, high-density lipoprotein cholesterol; IQR, interquartile range; LDL-C, low-density lipoprotein cholesterol; NA, not ap-
plicable; SDS: standard deviation score.
aAnalyses adjusted for age, age2, and sex.
bP value calculated using logarithmically transformed variables.
P values in bold indicate P < 0.05.
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in Spanish adolescents (n = 168; age: 12-16 years) with overweight or 
obesity. At baseline, the GRS was positively associated with BMI SDS 
and fat mass, and following 3 months of obesity treatment, the GRS 
was inversely associated with changes in both BMI SDS and fat mass 
(15). These findings suggest that a GRS comprising adult obesity and/
or BMI susceptibility loci and not necessarily childhood BMI-specific 
loci may also influence baseline BMI SDS in adolescents, and that a 
high genetic susceptibility, as based on the nine included SNPs, may 
influence treatment outcome. In the Spanish study, however, the adoles-
cents were treated according to a more intensive program based on food 
intake questionnaires, individualized balanced diet, physical activity, 
and weekly group sessions (15). In comparison, our study consisted of 
an individualized treatment plan containing 15 to 20 items of advice 
regarding the implementation of the lifestyle changes and individual 
consultations every 2 months (20). Furthermore, our study comprised 
a larger study population of both children and adolescents, and the 
duration of the lifestyle intervention was longer, ranging from 6 to 24 
months. Discrepancy between the reported effects of the applied GRSs 
may thus be due to differences in selected SNPs as well as differences 
in study and intervention methodology.
As more genetic variants associated specifically with childhood BMI or 
childhood obesity are identified, we will likely gain a better understand-
ing of how the effect of these gene variants differ compared with gene 
variants associated exclusively with adulthood obesity. In time, this can 
expand our understanding of biological pathways influencing obesity 
development differently during childhood and adulthood. Future stud-
ies examining cumulative effects of childhood BMI susceptibility loci 
are thus likely to include a larger number of genetic loci, and such stud-
ies may divide susceptibility SNPs into pathway-specific GRSs as a 
means to examine metabolic effects from a pathway perspective.
A strength of the present study was that we constructed a GRS com-
prising 15 SNPs known to be associated with childhood BMI (10). 
Furthermore, the present study included a relatively large study pop-
ulation compared with similar previous studies in children, especially 
in our analyses of intervention outcome. Importantly, the children and 
adolescents with overweight and obesity underwent treatment using 
The Children’s Obesity Clinic protocol, which has, in several nonran-
domized studies, shown improvement in metabolic risk variables and 
psychosocial well-being, including degree of obesity in both patients 
and their parents (20,36), blood pressure (37), plasma lipid fractions 
(38), body composition (39), liver and muscle fat content (40), and 
quality of life (41,42).
A limitation of our study is that the selected 15 childhood BMI sus-
ceptibility SNPs were identified in a sample of children aged 2 to 10 
years (10), whereas our population included children and adolescents 
between 6 and 18 years of age. Although the cumulative effect of these 
SNPs may not be directly comparable between the study samples, we 
demonstrated that the GRS was significantly associated with BMI 
SDS in children and adolescents above 10 years of age. Furthermore, 
as the lifestyle intervention program was highly individualized, mea-
sures of compliance were not registered, and statistical analyses were 
therefore performed using an intention-to-treat approach. Finally, as we 
have used data from a clinical database, information on family history 
of diabetes, coronary vascular disease, and related diseases were not 
systematically obtained, and statistical analyses could therefore not be 
adjusted for these potential confounders. Likewise, as the children and 
adolescents were not assessed according to pubertal development, sta-
tistical analyses were not adjusted accordingly.
Conclusion
A GRS for childhood BMI was associated with increased BMI SDS 
in Danish children and adolescents but was not associated with other 
BMI-related cardiometabolic measures at baseline. The GRS was not 
associated with the outcome of 6 to 24 months of structured lifestyle 
intervention, as assessed by changes in BMI SDS, systolic or diastolic 
BP, and related biochemical measures. Our study indicates that chil-
dren and adolescents with overweight or obesity are likely to obtain 
a similar decrease in degree of obesity regardless of their common 
variant genetic susceptibility for childhood obesity.O
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